MKI67 and neoplasm: Accompanying the reduction in tumor growth, Ki67+ proliferating NB cells in SK-N-AS xenografts were significantly reduced in the PlGF-shRNA group by 55% as compared to controls (p < 0.001; Figure 4C,D).